Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Increased prevalence of lymphoid tissue inducer cells in the cerebrospinal fluid of patients with early multiple sclerosis.
Reduced cortical microvascular oxygenation in multiple sclerosis: a blinded, case-controlled study using a novel quantitative near-infrared spectroscopy method.
Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation.
Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions.
Characteristics of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Taking Injectable and Oral Disease Modifying Treatments (Dmt) In Europe (Eu).
Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach.
Construction and validation of the chronic acquired polyneuropathy patient-reported index, "CAP-PRI:" a disease-specific, health-related quality of life instrument.
Onset-adjusted incidence of multiple sclerosis in the Girona province (Spain): Evidence of increasing risk in the south of Europe.
Should MRI be the primary endpoint of phase 3 trials in multiple sclerosis?
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
Erythropoietin Levels in Patients with Multiple SclerosisComplicated with Anemia.
Achieving valid patient-reported outcomes measurement: a lesson from fatigue in multiple sclerosis.
Primary Position Upbeat Nystagmus during an Acute Attack of Multiple Sclerosis.
Increased sleep fragmentation in experimental autoimmune encephalomyelitis.
Assessment of microRNA-related SNP effects in the 3' untranslated region of the IL22RA2 risk locus in multiple sclerosis.
Development of [(3)H]2-Carboxy-4,6-dichloro-1H-indole-3-propionic Acid ([(3)H]PSB-12150): A Useful Tool for Studying GPR17.
Demyelinating CNS Lesions in a Teenager.
Multiple sclerosis: Does low vitamin D level during pregnancy increase the risk of MS?
[Analysis of a series of cases with an initial diagnosis of acute disseminated encephalomyelitis over the period 2000-2010].
The diagnosis of chronic inflammatory demyelinating polyneuropathy: a Delphi-method approach.
Is MS an inflammatory or primary degenerative disease?
[Molecular targeted therapy for neuroimmunological diseases].
A case of neuromyelitis optica harboring both anti-aquaporin-4 antibodies and a pathogenic mitochondrial DNA mutation for Leber's hereditary optic neuropathy.
Proceedings of the 6th Dubrovnik International Conference on Multiple Sclerosis, 10-12 May 2012, Dubrovnik, Croatia.
Dimethyl fumarate for treating relapsing multiple sclerosis.
Pages
« first
‹ previous
…
591
592
593
594
595
596
597
598
599
…
next ›
last »